WASHINGTON — Former President Joe Biden is receiving radiation and hormone therapy as part of a new phase of treating the aggressive form of prostate cancer he was diagnosed with after leaving office, ...

Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former president confirmed to ABC News. "As part of a treatment plan for prostate cancer, ...

The former president's office announced his prostate cancer diagnosis in May. Former President Joe Biden is now receiving radiation therapy for his prostate cancer, a spokesperson for the former ...

Theresa Gaffney is the lead Morning Rounds writer and reports on health care, new research, and public policy, with a particular interest in mental health, gender-affirming care, and LGBTQ+ patient ...

The practice surged in the 1980s and 1990s, before medical groups began warning it was harmful. By Ellen Barry As a teenager, Julie Rodgers attended Tuesday night group therapy sessions in which young ...

Although the Endocrine Society guidelines recommend TRT for men with testosterone levels ≤ 300 ng/dL in two morning samples, a primary concern is its potential to exacerbate prostate-related ...

A recent episode of the hit Hulu comedy "Only Murders in the Building" highlights a hormone therapy that many men request as they get older. Steve Martin’s character, Charles-Haden Savage — a ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min The Japanese pharma giant ...

Radiation therapy could be an underused tool to reduce pelvic relapse risk for patients with locally advanced, muscle-invasive bladder cancer, according to results of a new phase III randomized trial.

Biogen has discontinued all gene therapy programs using adeno-associated virus (AAV) capsids, instead shifting resources to modalities that have the highest likelihood of achieving better treatment ...

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...

Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell Tumors We performed a post hoc analysis of a single-center phase II trial ...